Polycystic ovary syndrome among patients with type 2 diabetes mellitus in duhok city, kurdistan region of iraq
Abstract
ABSTRACT
Background: PCOS is the most common endocrine disorders with a potential to cause short- and long-term comorbidities especially T2DM. The present study was conducted to determine the prevalence of PCOS among type 2 diabetic patients in Duhok City, Kurdistan Region of Iraq.
Methods: This study is an observational study conducted through cross-sectional design. Type 2 diabetic women (n = 200) at reproductive age were included. PCOS was confirmed using the clinical, hormonal and radiological findings according to Rotterdam criteria. Data of the study are determined in frequency distribution whether mean and standard deviation or frequency and percentage.
Results: The prevalence of PCOS was high (81.5%) among type 2 diabetic women. The frequency of clinical findings in the type 2 diabetic patients revealed that majority of them had clinical feature and hormonal features while 77% of them had positive ultrasound features, 49% were newly diagnosed diabetic patients and 44.5% of the patients on metformin medication.
Conclusions: PCOS is highly prevalent in type 2 diabetic patients. In-depth research is required to determine the appropriate methods to identify susceptible women including genetic studies in order to prevent or treat or limit the implications.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 200 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.